InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (8 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
8
T+90 hit rate
25%
T+90 mean return
-0.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Moss David J, Chief Financial Officer. Insider active across 1 company, notably Inmune Bio, Inc.. Aggregated, 18 disclosures have been recorded. Split: 5 buys · 8 sells. Total volume traded: €734k. Activity tracked since 7 July 2021. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
9,014 shares@ US$1.400.031% mcap0.9% of flowCommon StockSEC:0001213900-26-075736:0
10,000 shares@ US$5.28684.0% of flowCommon StockSEC:0001213900-24-083348:0
Ideal exit: 27 Jun 2025 (T+270)
7,690 shares@ US$6.3753.8% of flowCommon StockSEC:0001213900-24-079119:0
Ideal exit: 9 Jun 2025 (T+270)
18,028 shares@ US$8.3212.0% of flowCommon StockSEC:0001213900-24-035723:0
Ideal exit: 14 Jan 2025 (T+270)
18,028 shares@ US$8.3212.0% of flowCommon StockSEC:0001213900-24-035473:0
2,500 shares@ US$6.4251.3% of flowCommon StockSEC:0001213900-23-021235:0
Ideal exit: 12 Dec 2023 (T+270)
7,700 shares@ US$6.270.11% mcap5.7% of flowCommon StockSEC:0001213900-22-030208:0
Ideal exit: 20 Feb 2023 (T+270)
17,793 shares@ US$8.430.33% mcap17.3% of flowCommon StockSEC:0001213900-22-014504:0
1,025 shares@ US$20.000.043% mcap2.2% of flowCommon StockSEC:0001213900-21-056738:0
1,025 shares@ US$20.001.5% of flowCommon StockSEC:0001213900-21-056738
2,079 shares@ US$20.000.087% mcap4.5% of flowCommon StockSEC:0001213900-21-055418:0
2,079 shares@ US$20.003.0% of flowCommon StockSEC:0001213900-21-055418
1,142 shares@ US$20.000.048% mcap2.5% of flowCommon StockSEC:0001213900-21-054640:0
1,142 shares@ US$20.001.7% of flowCommon StockSEC:0001213900-21-054640
25,000 shares@ US$3.917.0% of flowCommon StockSEC:0001213900-21-037560
25,000 shares@ US$3.910.20% mcap10.5% of flowCommon StockSEC:0001213900-21-037560:0
8,698 shares@ US$20.008112.5% of flowCommon StockSEC:0001213900-21-036353
8,698 shares@ US$20.00810.36% mcap18.7% of flowCommon StockSEC:0001213900-21-036353:0
18 of 18 declarations
About Moss David J
David J. Moss is the Chief Financial Officer, Treasurer, and Secretary at Inmune Bio, Inc. He is responsible for the financial management of the company, including financial planning and risk management. With a strong background in finance, he plays a crucial role in strategic direction and financial decision-making. His expertise contributes to the growth and stability of Inmune Bio.
